NEURO61

Session information

[held on paper]Oral Session

[O-14] Oral Session 14
Motor Neuron Disease 2

Kota Bokuda1,2, Kentaro Hayashi1,2, Miki Murakami1,3, Naomi Ishii1,3, Kazuho Ogawa1,4, Yuki Aoyama1,5, Akiko Nose1,5, Toshio Shimizu1,2 (1.Nutrition Support Team, Tokyo Metropolitan Neurological Hospital, 2.Department of Neurology, Tokyo Metropolitan Neurological Hospital, 3.Department of Nursing, Tokyo Metropolitan Neurological Hospital, 4.Department of Pharmaceutical, Tokyo Metropolitan Tama Medical Center, 5.Department of Nutrition, Tokyo Metropolitan Neurological Hospital)

Haruhiko Motegi1, Shusaku Omoto1, Taiji Mukai2, Takahiro Maku1, Maki Takahashi1, Shiho Akiyama1, Hiroki Takatsu1, Takeo Sato1, Teppei Komatsu1, Kenichiro Sakai1, Tadashi Umehara1, Hidetaka Mitsumura1, Hidetomo Murakami1, Yasuyuki Iguchi1 (1.The Jikei University School of Medicine, Department of Neurology, 2.The Jikei University School of Medicine, Department of Neurology, Kashiwa Hospital)

Chiho Ishida1, Kiyonobu Komai1, Kazuya Takahashi1, Yuko Motozaki1, Kenji Sakai2, Keiko Nakamura-shido2, Koji Hayashi1, Sadao Hikishima1, Atsuro Tagami3, Masahito Yamada2 (1.Department of Neurology, National Hospital Organization Iou National Hospital, 2.Department of Neurology and Neurobiology of Aging, Kanazawa University Graduate School of Medical Sciences, 3.Department of Respiratory Medicine, National Hospital Organization Iou National Hospital)